French physician and politician (1738-1814) whose name became synonymous with the 'humane' instrument of execution whose use he proposed to the government during the French Revolution. Manuscript DS in French, signed "Guillotin," one page, 7.5 x 9.5, October 30, 1811. A fascinating medical report, which reads, in part (translated): “A bloodletting of about four ounces having been done on the 28th of this month according to the directions given in the consultation of Oct. 13, and this bloodletting having dissipated the symptoms which made it necessary, the consulting doctors are of the opinion that the same bloodletting should be repeated, if the symptoms which made it necessary, reappear. It will be particularly necessary to study the patient's condition at the oncoming of her periods, to observe the symptoms which could indicate a blood turgescence and a strain to her bosom and then to undertake a small bloodletting at the latest a week before the return of her period. They are also of the opinion that the dietary and therapeutic means established during the last consultation be strictly adhered to.” Boldly signed at the conclusion by Guillotin. Archivally matted and framed with two photos and a caption to an overall size of 27 x 14.5. In fine condition, with some scattered light stains, and chips to the frame. An uncommon format with exceptional procedural content from Guillotin's many years as a trusted and well-respected physician.
This item is Pre-Certified by PSA/DNA
Buy a third-party letter of authenticity for
$75.00
*This item has been pre-certified by a trusted third-party authentication service, and by placing a bid on this item, you agree to accept the opinion of this authentication service. If you wish to have an opinion rendered by a different authenticator of your choosing, you must do so prior to your placing of any bid. RR Auction is not responsible for differing opinions submitted 30 days after the date of the sale.
We use cookies on this site to improve your experience. By using this site, you accept our use of cookies. To learn more, please see our Privacy Policy.
